- $12.37m
- -$270.42m
- $92.42m
- 32
- 92
- 13
- 42
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 40.1 | 0 | 291 | 260 | 92.4 |
Cost of Revenue | |||||
Gross Profit | — | 0 | 12.9 | -10.6 | 14.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 67.4 | 7.57 | 334 | 475 | 97.2 |
Operating Profit | -27.3 | -7.57 | -43.1 | -215 | -4.81 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.32 | -7.51 | -52.4 | -230 | -5.79 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.9 | -7.51 | -52.4 | -230 | -6.42 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -9.9 | 4.4 | -49.3 | -229 | -3.65 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.9 | 4.4 | -49.3 | -229 | -3.65 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -7.32 | -0.006 | -0.022 | -0.065 | -0.001 |